Controversies in the use of central nervous system stimulant medications in children with attention deficit hyperactivity disorder are discussed. Diagnostic issues, age of optimal use, side effects, effects on learning and ethical considerations are current issues. An animal model for the effects of chronic long-term high dose regimes is proposed.
References
1.
BradleyC. The behaviour of children receiving benzedrine. American Journal of Psychiatry1937; 94: 577–584
2.
WeissG. Controversial issues of the pharmaco-therapy of the hyperactive child. Canadian Journal of Psychiatry1981; 981: 26(6):385–392
3.
RutterMGrahamPYuleW. A neuropsychiatric study in Childhood. London: Heinemann1970
4.
LambertNSandovalJ. The prevalence of learning disabilities in a sample of children considered hyperactive. Journal of Abnormal Psychology1980; 8: 35–50
5.
LevyFHobbesG. The diagnosis of attention deficit disorder (Hyperkinesis) in children. Journal of the American Academy of Child Psychiatry1981:20:376–384
6.
SchwartzSAdamsTHallA. Event-related potentials in attention-deficit and learning disabled children. Delivered at a Symposium on ERP correlates of information processing: Normal and abnormal functioning. XXIV International Congress of Psychology, Sydney 1988
7.
SchleiferMWeissG.Hyperactivity in pre-schoolers and the effects of methylphenidate. American Journal of Orthopsychiatry1975; 45: 38
8.
ConnersC.K.Controlled trial of methylphenidate in pre-school children with minimal brain dysfunction. International Journal of Mental Health1975; 4: 61
9.
BarkleyRA. The effects of methylphenidate on the interactions of prescribed ADHD children with their mothers. Journal of the American Academy Child and Adolescent Psychiatry1988; 27: 336–341
10.
LevyF. The development of sustained attention (vigilance) and inhibition in children: Some normative data. Journal Child Psychology and Psychiatry1980; 21: 77–84
11.
WeissGHechtmanTrockenberg L. Hyperactive children grown up. The Guildford PressNew York London1986
12.
VarleyC. A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents. Psychopharmacology Bulletin1985;21(2): 216–221
13.
WenderPHWoodDRReimherrFW. Pharmacological treatment of attention deficit disorder, residual type (ADD, RT), “minimal brain dysfunction'7′hyperactivity” in adults. Psychopharmacology Bulletin1985;21(2):222–231
14.
SpragueRLSleaterEK. Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behaviourScience 977; 198: 1274–1276
15.
WerryJ. Drugs, learning and cognitive function in children — an update. Journal of Child Psychology and Psychiatry1988; 29: 129–141
16.
PelhamWEBenderMECaddellMA. Booth S, Moorer SH. Methylphenidate and children with attention deficit disorder: Dose effects on classroom academic and social behaviour. Archives of General Psychiatry1985; 42: 948–952
17.
KupietzSSWinsbergBGRichardsonEMaitinskySMendellM. Effects of methylphenidate dosage in hyperactive reading-disabled children: I. Behaviour and cognitive performance effects. Journal of American Academy of Child and Adolescent Psychiatry1988; 27,1:70–77
18.
SchmidtKKappraffMS. Diminished effectiveness of methylphenidate on cognitive tasks in attention deficit disorder with hyperactivity. Journal of Clinical Psychopharmacology1987; 7,3:204
19.
SaferDAllenRBonE. Depression of growth in hyperactive children on stimulant drugs. New England Journal of Medicine1972; 287: 217
20.
EisenbergL. The hyperkinetic child and stimulant drugs. New England Journal of Medicine1972; 287: 249
21.
SatterfieldJHCantwellDPSchellD. et al Growth of hyperactive children treated with methylphenidate. Archives General Psychiatry1979; 36: 212
22.
MattesJAGittelmanR. Growth of hyperactive children on maintenance regimen of methylphenidate. Archives General Psychiatry1983; 40: 317–321
ConnellPH. Amphetamine Psychosis. London: Chapman and Hall Ltd, 1958
25.
CohenDJLeckmanJF. Tourettes syndrome: Advances in treatment and research. Journal of American Academy of Child Psychiatry1984; 23: 123–125
26.
SverdJCurleyADJandorfLVolkerszL. Behaviour disorder and attention deficits in boys with Tourette Syndrome. Journal of the American Academy of Child and Adolescent Psychiatry1988; 27,4:413–417
27.
CommingsDECommingsBG. Tourette's Syndrome and Attention Deficit Disorder with Hyperactivity: Are they genetically related?Journal of the American Academy of Child Psychiatry1984; 23: 138–146
ZametkinAJRapoportJ. Neurobiology of Attention Deficit Disorder with Hyperactivity: Where have we come in 50 years?Journal of the American Academy of Child and Adolescent Psychiatry1987; 26,5:676–686
30.
JennerPBoyceSMarsdenCD. Effects of repeated L-DOPA administration on striatal dopamine receptor function in the rat. In: FahnSMarsdenCDJennerPTeychenneP eds. Recent Developments in Parkinson's Disease. New York: Raven Press1986
31.
KlawansHLGoetzCNausiedaPAWeinerWJ. Levodopa-induced dopamine receptor hyper-sensitivity. Archives of Neurology1977; 2: 125–129
32.
AmanMG. Psychotropic drugs and learning problems: a selective review. Journal Learning Disability1980; 13: 87–97
33.
GadowKO. Effects of stimulant drugs on academic performance in hyperactive and learning disabled children. Journal Learning Disability1983; 16: 190–299
34.
PelhamWE. The effects of psychostimulant drugs on learning and academic achievement in children with Attention Deficit Disorders and Learning Disabilities. In: Psychological and Educational Perspectives in Learning Disabilities, eds. FergusenJKWongBYLAcademic Press, 1986. New York
35.
DouglasVIBarrRGO'NeillMEBrittanBG. Short term effects of methylphenidate on the cognitive, learning academic performance of children with attention deficit order in the laboratory and the classroom. Journal of Child Psychology and Psychiatry27;191–211
36.
RichardsonEKupietzSSWinsbergBGMaitinskySMendellW. Effect of methylphenidate dosage in hyperactive reading disabled children: II Reading Achievement. Journal of American Academy of Child and Adolescent Psychiatry1988; 27,1:78–87
37.
LevyFHornKDalglishR. Relation of attention deficit and conduct disorder to vigilance and reading lag. Australian and New Zealand Journal of Psychiatry1987; 21: 242–245
